Showing results (71-80 of 241) with videos related to
Sort By:
Pageof 25
Diabetes|April 28, 2005
The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic menLu Qi, Tricia Li, Eric Rimm, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 3, 2011
Angiotensin II receptor blocker pretreatment of rats undergoing sudden renal ablationHye Won Park, Youngki Kim, Kee Hyuck Kim, et al.Diabetes Care|May 13, 2011
Microalbuminuria in patients with cystic fibrosisMelanie Lind-Ayres, William Thomas, Bonnie Holme, et al.Journal of the American Society of Nephrology : JASN|March 5, 2020
Accumulation of Globotriaosylceramide in Podocytes in Fabry Nephropathy Is Associated with Progressive Podocyte LossBehzad Najafian, Camilla Tøndel, Einar Svarstad, et al.Journal of Molecular Medicine (Berlin, Germany)|December 17, 2008
The role of HSP70 on ENPP1 expression and insulin-receptor activationAntonella Marucci, Giuseppe Miscio, Libera Padovano, et al.Nature Communications|August 7, 2025
Urinary Complement proteome strongly linked to diabetic kidney disease progressionZaipul I Md Dom, Salina Moon, Eiichiro Satake, et al.Diabetes|April 29, 2006
Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetesLu Qi, Alessandro Doria, JoAnn E Manson, et al.Kidney International|December 17, 2010
Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry diseaseBehzad Najafian, Einar Svarstad, Leif Bostad, et al.Diabetes|December 25, 2003
Genetic variation at the adiponectin locus and risk of type 2 diabetes in womenFrank B Hu, Alessandro Doria, Tricia Li, et al.Journal of the American College of Cardiology|December 14, 2011
Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studiesLu Qi, Layla Parast, Tianxi Cai, et al.Pageof 25